Given that the lungs and the heart share the thoracic cavity, respiratory diseases often influence cardiovascular physiology. In COPD, for example, previous research has shown that pulmonary hyperinflation can compress the heart, 1 cause pulmonary hypertension, and reduce left ventricular filling, stroke volume, and cardiac output. 2 For pulmonary hypertension in particular, using CT imaging to assess those at risk from pulmonary disease has become increasingly common by measuring the ratio of the diameters of the main pulmonary artery to the ascending aorta (PA/A). 3 In other obstructive lung diseases such as cystic fibrosis and COPD, this ratio has also been associated with increased odds of both past and future exacerbations. 4, 5 In this issue of CHEST, Ash et al 6 used CT measurements of the PA/A ratio and an automated method for estimating the epicardial right ventricular (eRV) and left ventricular (eLV) volumes and their ratio (eRV/eLV) as potential predictors of asthma severity. This study used volumetric, noncontrast, non-ECG-gated chest CT scans from 233 patients with both severe and nonsevere asthma from the third phase of the Severe Asthma Research Program (SARP) as well as a smaller group of healthy control subjects. The investigators measured low attenuation areas (LAA), air trapping, pulmonary artery (PA) diameter, ascending aorta diameter, the presence of emphysema, and estimated cardiac ventricular size. Overall, the study detected no association between the PA/A or the eRV/eLV on asthma severity or exacerbations in the multivariate analyses. The study did, however, find that patients with severe asthma had smaller left, right, and biventricular volumes than healthy control subjects and patients with mild to moderate asthma. Perhaps more importantly, in multivariate analysis, the investigators discovered that patients with smaller ventricular volumes had increased rates of asthma exacerbations, both in the year prior to enrollment and during follow-up.
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These results 6 are perhaps not altogether surprising. The SARP investigators have previously reported CT imaging evidence of decreased size of the peripheral pulmonary vasculature (pruning) in patients with asthma and that this finding was correlated with a 150% increase in the odds of an asthma exacerbation. 7 A PA/A ratio > 1, however, is associated with pulmonary hypertension; although this finding is common in COPD, 8 it is not frequently seen with asthma. In an autopsy study by Saetta et al 9 of patients who died of asthma attacks, the peripheral pulmonary arteries adjacent to occluded and inflamed bronchioles exhibited evidence of inflammation, although none of the patients had narrowed lumens of the peripheral pulmonary arteries compared with the control group, evidence of the morphologic changes of chronic hypoxia or cor pulmonale. The authors of the current study 6 concluded that the pulmonary hypertension in COPD is likely due to parenchymal destruction and regional hypoxia, both of which are more pronounced in COPD than in asthma. This finding is supported by previous research showing that, among other risk factors, use of supplemental oxygen and a larger percentage of emphysema on CT imaging is associated with a PA/A ratio > 1 in COPD. 5 As for the correlation between decreased ventricular volumes and asthma exacerbations, decreased heart size has been previously noted on chest radiographs in obstructive lung disease. 1, 6 Traditionally, this has been believed to be due in part to hyperinflation as well as a visual effect caused by the lowering of the diaphragm, leading to rotation of the cardiac apex. In the current study by Ash et al, 6 the association of decreased ventricular volumes and asthma exacerbations was observed after correcting for LAA, lung volume, and percent predicted FEV 1 among other risk factors. Lung volumes and LAA both had a statistically significant correlation with ventricular volumes in this study; however, the correlations were overall weak and likely do not explain a significant amount of the change in ventricular volumes in patients with asthma. Decreasing cardiac chamber size has been reported with increasing severity of COPD, 10 and the study by Ash et al 6 implies this scenario may be similar in asthma as well.
The absence of a large effect of height-normalized CT lung volumes on cardiac volume seen in this study 6 suggests that total lung capacity alone is not the predominant driver of this association. In the absence of severe airflow limitation, the cross-sectional area of the heart is significantly larger on expiratory CT imaging than on inspiratory CT imaging, and this finding is associated with the upward excursion of the diaphragm. 1 In a study of dynamic ventilation CT scans in patients with COPD, Xu et al 1 showed that the cardiac crosssectional area on CT imaging was smaller in patients with COPD on inspiration than the control group and that this area decreased with expiration as opposed to increasing as it did in healthy control subjects. Applying comparable techniques in asthma could determine if a similar underlying mechanism, such as increased intrathoracic pressure, is responsible for the decreased ventricular volumes seen in patients with asthma in the study by Ash et al. 6 This may help better appreciate the compliance of the lungs, diaphragm, and chest wall in this cohort and their effects on the heart more than a static CT measure of lung volume alone.
This study 6 suggests that changes in cardiac ventricular volume are associated with increased asthma exacerbations independent of lung volumes or LAA. There are several key limitations, however, that further research could help elucidate the pathophysiology for this effect. The CT scan measurements of cardiac volume were epicardial, and detection of the intraventricular septum was limited by the lack of contrast. This makes it difficult to determine if the changes in cardiac volume were related to decreased filling, decreased ventricular wall mass, or some combination of the two. It also made comparing the right and left ventricle sizes and their ratio limited. It would be interesting, in future research, to assess the effect of functional MRI measures of segmental lung defects with ventilation and cardiac chamber sizes in patients with mild and severe asthma compared with healthy control subjects. The measurements were also performed at only one point in time, making it impossible to determine if the effect on ventricular sizes was reversible or progressive. Despite these limitations, the reduced cardiac ventricular size may serve as a useful CT biomarker of more severe asthma, and further investigation may lead to ways to prevent and reduce the significant burden of asthma exacerbations.
